Brief: Theravance Biopharma Q1 Operating Income USD -11.207 Million
13/05/2024 21:05
May 13 (Reuters) - Theravance Biopharma Q1 adjusted net income USD -4.544 million vs. IBES estimate USD -12.5 million. * Q1 net income USD -11.664 million
Recent news on Theravance Biopharma
See all newsTheravance Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ireland's Theravance Biopharma Q2 revenue rises 11% but misses estimates
Brief: Theravance Biopharma Q2 Operating Income USD -8.277 Million
Press Digest: Canada - June 30
Deals of the day-Mergers and acquisitions